Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs

<< Previous

Bullboard Posts

Next >>

Post by guerreiroon Dec 08, 2010 12:45pm

281 Views

Post# 17818791

What a Christmas present for HBM & Insiders.

Finally we see the picture!!!. Why the stock was being held back!!!.

Just as I had predicted, cheap financing. What lies ahead ??Once financing closes, possible more options for insiders and the appointment of a few of HBM's Directors!!!??

Investor Relations-- First Canadian Capital can finally start doing what they were hired to do!! ** promote HLO**.

Where does PNP fit in the picture?. Why the cross of 1/2 million shares of HLO @ .51.3 cents to PNP and its CEO.

Patience; We will have to wait for our Christmas present later!!! HLO could easily go to $2.50 / $3.50 given the market conditions and metals prices.

I new that something big was going on behind the scenes. I will just keep buying on pullbacks for now. The past is history, the future is mystery and this moment is a gift.

As a shareholder I would like to see more transparency by HLO management.